Semi-quantitative assessment of 99tcm-sestamibi uptake in lung cancer: Relationship with clinical response to chemotherapy

Nuclear Medicine Communications

Volumn 18, Issue 11, 1997, Pages 1087-1097

  Ceriani, L ^a   Giovanella, L ^a   Bandera, M ^a   Beghe, B ^a   Ortelli, M ^a   Roncari, G ^a  

^a University Hospital   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; DIAGNOSTIC IMAGING; FEMALE; HUMAN; IMAGE ANALYSIS; LUNG CANCER; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; LYMPH NODE METASTASIS; MALE; RECEIVER OPERATING CHARACTERISTIC; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TOMOGRAPHY;

EID: 0030819224     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1080/00006231-199711000-00013     Document Type: Article

References (34)

1. Abdel-Dayem HM, Scott A, Macapinlac H et al. Tracer imaging in lung canccr. Eur j Nucl Med 1994; 21: 57-81.
2. Barrington SF, O’Doherty. Imaging in lung cancer. Nucl Med Comimnt 1996; 17: 173-175.
3. Hassan IM, Sahweil A, Costantinides C et al. Uptake and kinetics of Tc-99m hexakis 2-methoxy isobutyl isonitrile in benign and malignant lesions in the lung. Clin Nucl Med 1989; 14: 333-340.
4. Aktolun C, Bayhan H, Pabuccu Y et al. Assessment of tumour necrosis and detection of mediastinal lymph node mestastasis in bronchial carcinoma with technotium-99m sestamibi imaging: Comparison with CT scan. Eur J Nucl Med 1994; 21: 973-979.
5. Muller SP, Reiners C, Pass M et al. Tc-99m MIBI Tl-201 uptake in bronchial carcinoma (abstract). J Nucl Med 1989; 30: 845.
6. O’Doherty MJ, Kettle GA, Collins REC, Coakley AJ. Parathyroid imaging with technetium-99m-sestamibi: Preoperative localization and tissue uptake studies. J Nucl Med 1992; 33: 313-318.
7. O’Tuama LA, Packard AB, Trever ST. SPECT imaging of pediatric brain tumors with hexakis (methoxyisobutyliso-nitrile) technetium(I). J Nucl Med 1990; 31: 2040-2041.
8. Schillaci O, Scoparino F, Scarpini M et al. Is Tc-99m MIBI uptake in breast cancer related to neoangiogenesis? (abstract). Eur J Nucl Med 1994; 21: 747.
9. Moretti JL, Caglar M, Cordobes MD et al. Can nuclear medicine predict response to chemotherapy? Eur J Nucl Med 1995; 2: 97-100.
10. Piwnica-Worms D, Chiu ML, Budding M et al. Functional imaging of multidrug-resistant Pglycoprotein with an organotechnetium complex. Cancer Res 1993; 53: 977-984.
11. Cordobes MD, Starzec A, Delmon-Moingeon L et al. Technetium 99-m-sestamibi uptake by human benign and malignant breast tumour cells: Correlation with mdr gene expression. J Nucl Med 1996; 37: 286-289.
12. Moretti JL, Caglar M, Boaziz C et al. Sequential functional imaging with technetium-99m hexakis-2-methoxyisobutyl- isonitrile and indium-111 octreotide: Can we predict the response to chemotherapy in small cell lung cancer? Eur J Nucl Med 1995; 22: 177-180.
13. Chabner BA. The role of drugs in cancer treatment. In: Chabner BA, ed. Pharmacologic principles of cancer treatment. Philadelphia, PA: WB Saunders, 1982: 3-14.
14. Ihde DC. Chemotherapy of lung cancer. N Engl J Med 1992; 12: 1434-1441.
15. Ross EM. Pharmacodynamics: Mechanisms of drug action and the relationship between drug concentration and effect. In: Goodman Gilmann A, Rail TW, Nies AS, Taylor P, eds. The pharmacological basis of therapeutics. New York: McGraw-Hill, 1992: 33-49.
16. Gottesman MM, Pastan I. The multidrug transporter, a double edged sword.J Biol Chew 1988; 263: 12163-12166.
17. Endicott JA, Ling V. The biochemistry of P-glycoprotein- mediated multidrug resistance. Annu Rev Biochetu 1989; 58: 137-171.
18. Croop JM, Gros P, Housman DE. Genetics of multidrug resistance. J Clin Invest 1988; 81: 1303-1309.
19. Morrow CS, Cowan KH. Mechanisms of antineoplastic drug resistance. In: De Vita V, Heilman S, Rosenberg SA, eds. Cancer: Principles and practice of oncology. Philadelphia, PA: JB Lippincott, 1993: 340-348.
20. Caner B, Kitapcl M, Unlu M et al. Technetium-99m-sesta- mibi uptake in benign and malignant bone lesions: A comparative study with technetium-99m-MDP J Nucl Med 1992; 33: 319-324.
21. Wackers FJ, Berman DS, Maddhai J et al. Technetium-99m hexakis 2-methoxyisobutyl isonitrile: Human distribution, dosimetry, safety and preliminary comparison to thallium- 201 for myocardial perfusion imaging. J Nucl Med 1989; 30: 301-311.
22. Crane P, Laliberti R, Heminway S et al. Effect of mitochondrial viability and metabolism on Tc-99m sestamibi myocardial retention. Eur J Nucl Med 1993; 20: 20-25.
23. Piwnica-Worms D, Kronague JF, Holman BL et al. Hexakis (carbomethoxyisopropylisonitrile) technetium(1): A new myocardial perfusion imaging agent. Binding characteristics in cultured chick heart cells. J Nucl Med 1988; 29: 51-61.
24. Piwnica-Worms D, Kronauage JF, Chiu ML. Uptake and retention of hexakis (2-methoxyisobutylisonitrile) technetium(l) in cultured chick myocardial cells: Mitochondrial and plasma membrane potential dependence. Circulation 1990; 82: 1826-1838.
25. Rocco TP, Dilsizian V, Strauss HW et al. Technetium-99m isonitrile myocardial uptake at rest. II: Relation to clinical markers of potential viability. J Ant Coll Cardiol 1989; 14: 1678-1684.
26. Pastan I, Gottesman M. Multiple drug resistance in human cancer. N Engl/Med 1987; 316: 1388-1392.
27. Van der Valk P, Van Kalken CK, Ketelaars H et al. Distribution of multidrug resistance-associated (P-glycoprotein) in normal neoplastic human tissues. Ann Oncol 1990; 1: 55-64.
28. Cordon-Cardo C, O’Brien JP, Boccia J et al. Expression of the multidrug resistance gene product (P-glycoprotein) in human normal and tumour tissue. J Histochcni Cytochcin 1990; 38: 1277-1287.
29. Brophy NA, Marie JP, Berry JM et al. Expression of the multidrug resistant gene mdrl in leukemia and lymphoma cells. Am Ass Clin Oncol 1989; 8: 211.
30. Holzmayer TA, Hilsenbeck S, Von Hoff DD et al. Clinical correlates of MDR (P-glycoprotein) gene expression in ovarian and small cell lung carcinomas. J Natl Canccr Inst 1992; 84: 1486-1491.
31. Scagliotti GV, Michelotto F, Kalikatzaros G et al. Detection of multidrug resistance associated p-170 glycoprotein in previously untreated non-small cell lung cancer. Anticancer Res 1991; 11: 2207-2210.
32. Chan HSL, Thomas PS, Haddad G et al. Immunohisto-chemical detection of P-glycoprotein: Prognostic correlation in soft tissue sarcoma of childhood. J Clin Oncol 1990; 8: 689-704.
33. Ma DDF, Davey RA, Harman DH et al. Detection of multidrug resistance phenotype in acute non-lymphoblastic leukemia. Lancet 1987; i: 135-137.
34. Bom HS, Kim YC, Song HC et al. Tc-99m sestamibi uptake in lung cancer: A predictor of response to chemotherapy (abstract). J Nucl Med 1996; 37: 67.